Albumin Market Outlook 2031

  • The global albumin market was valued at US$ 4.6 Bn in 2020
  • It is estimated to expand at a CAGR of 6.1% from 2021 to 2031
  • The global albumin market is expected to reach the value of US$ 8.1 Bn by the end of 2031

Analysts’ Viewpoint on Albumin Market Scenario

In order to emerge resilient to the COVID-19 outbreak, companies in the albumin market are expected to adopt contingency planning across departments to revive organizational revenue and capital expenditure. Extraction of recombinant human serum albumin and processing incur significant cost & expertise. Additionally, it requires expert staff to handle operations, as the recombinant technology attracts stringent laws and regulations. Moreover, cost associated with refinement of recombinant albumin to attain high purity is a major concern among the industry players. This acts as a major restraint for the albumin market. Hence, companies should work closely with governments in developed economies of North America and Europe to employ supportive regulatory policies that help to lower the cost of albumin production. They should diversify business activities in developing economies such as India and China to capitalize on value-grab opportunities.

Rise in Investments for Life Sciences Catalyzing Demand for Albumin

Geographically, North America and Europe are projected to be highly attractive markets for albumin during the forecast period. Rise in investments in life sciences by a large number of biopharmaceutical companies and research institutes is expected to boost the albumin market in these regions throughout the assessment period.

The demand for albumin is high in countries such as India and China. However, the uptake of these therapeutics is low due to the lack of awareness about these products and their therapeutic uses. Hence, awareness programs conducted by healthcare organizations which include International Plasma Awareness Week, to help increase awareness about plasma donation and the different plasma protein therapies available, along with their potential uses are expected to increase the demand for these therapeutics in treating various conditions.

To know the scope of our report Get a Sample on Albumin Market

Improvements in Business Flow amid COVID-19 Outbreak Benefitting Manufacturers

Companies in the albumin market are maintaining optimum inventory levels to cater to mission-critical projects in the healthcare industry amid the ongoing coronavirus pandemic. Different regions of the world are showing signs that supply chains are recovering as the production & movement of goods are speeding up. Manufacturers based in the Western Hemisphere have been making significant progress in the past few years to secure themselves against volatility in supply from Asia, China in particular, by moving the bulk production to their respective countries.

Get a glimpse of the in-depth analysis through our Report Brochure

Chemically-defined Albumin Holds Promising Potentials for Vaccine Innovation

Companies in the albumin market are launching chemically defined, blood and plant hydrolysate-free cell culture media for vaccine manufacturing that outperforms popular VERO media by enabling robust VERO cell expansion and production of difficult-to-express virus types.

Albumin is being widely used as a versatile drug carrier in systems such as albumin fusion protein, albumin-drug nanoparticles, and pro-drugs. It is used as a drug carrier for the treatment of various diseases such as rheumatoid arthritis, diabetes, cancer, and hepatitis.

It also has the ability to bind to extraordinarily diverse range of molecules, as it provides depository for various compounds. These factors make albumin most suitable to be used as an excipient in vaccine and drug production.

Expanding operations in future? To get the perfect launch ask for a custom report

Technological Advancements Help Overcome High Cost Development of Albumin Therapeutics

Increase in usage of albumin as multifunctional excipient, shift toward usage of recombinant albumin, and grant of regulatory approvals are key factors that are driving the albumin market. However, high cost & expertise required to set up production plants and stringent regulatory criteria are restraining the growth rate of the market. Nevertheless, emerging markets such as India, China, Brazil, and South Africa present significant opportunities in the albumin market, owing to growing contract research manufacturing. Such findings are helping stakeholders in the albumin market to diversify their business activities in regions where regulatory standards are comparatively easier to adhere with.

Technological developments in drug formulation & drug delivery and increase in access to technologies such as use of albumin in cell culture media present lucrative opportunities for investors. Hence, investments by manufacturers in these developing markets, increase in contract research manufacturing, and rise in demand & awareness among end users are expected to boost the growth of the albumin market.

High Prevalence of Life-threatening Disorders Augmenting Demand for Albumin

In terms of product, the human serum albumin segment is anticipated to account for major market share of approximately 80%, in terms of revenue, during the forecast period. The growth of the segment can be attributed to the increase in prevalence of life-threatening disorders & conditions, especially liver diseases, infections, and cardiac surgeries leading to hypoalbuminemia. Other factors driving the segment include rise in adoption of albumin products and increase in usage of non-therapeutic applications across the world.

Based on application, drug delivery is expected to be the most attractive segment during the forecast period. Collaboration between pharmaceutical and biotechnology companies for the use of recombinant albumin-based drug delivery systems is likely to propel the growth of the segment. In terms of end-user, the pharmaceutical & biotechnology industry segment is expected to dominate the market throughout the assessment period. The segment was valued at US$ 500 Mn in 2017. Rise in research and developmental (R&D) activities for the development of technologically advanced products and increase in government funding are attributed to the growth of the segment.

Albumin Market: Overview

  • According to Transparency Market Research’s latest report on the global albumin market for the historical period 2017–2019 and forecast period from 2021 to 2031, rise in government support, increase in research funding, technological advancements, improved regulatory framework, and surge in prevalence of chronic liver & kidney diseases are projected to drive the global albumin market during the forecast period

Increase in Use of Albumin as Multifunctional Excipient: Key Driver

  • Albumin is a protein that is abundant in blood and is necessary for blood osmotic pressure regulation
  • It protects proteins from oxidation by acting as a powerful antioxidant that prevents protein therapeutics from being modified. It also acts as a blocking agent to prevent non-specific adsorption to glass and plastic surfaces and prevents aggregation of protein products during manufacturing and delivery.
  • In the past several years, hypoalbuminemia has become more frequent across the world owing to surge in the incidence of life-threatening disorders and ailments, such as heart-disease and liver disease. Additionally, increase in acceptance of albumin products, rise in recognition of recombinant albumin, and growing emphasis on non-therapeutic applications of albumin across multiple regions contribute to the growth of the global albumin market.

Shift toward Use of Recombinant Albumin: Major Driver

  • Recombinant albumin has emerged as a suitable product for use as an excipient in the manufacture of bio-therapeutics in order to overcome these challenges
  • In addition to preventing the spread of serum-derived disease agents, it provides benefits such as improved batch-to-batch consistency and breaking reliance on increasingly unpredictable supply chains
  • The grant of approvals by national regulatory authorities for novel recombinant albumin products developed by pharmaceutical and biotechnology organizations drive the global albumin market. Moreover, in January 2022, Bio Products Laboratory (BPL), a U.K.-based prominent manufacturer of plasma protein therapies, announced that the National Medical Products Administration (NMPA) granted the company a license to commercialize ALBUMINEX 25% product in China.

High Cost and Expertise Required to Set Up Albumin Production Plants

  • Extraction and processing of recombinant human serum albumin are time-consuming and expensive. Moreover, recombinant technology is subject to strict laws and regulations. Hence, it necessitates the use of expert personnel to manage operations.
  • The cost of refining recombinant albumin to achieve high purity is a major concern among industry players. This acts as a significant restraint of the market.

Albumin Market: Competition Landscape

  • This report profiles major players in the global albumin market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global albumin market is quite competitive, with the top ten players accounting for major share of the market and companies focusing on research & development to produce better pharmaceutical and vaccine products for the existing diseases
  • Leading players operating in the global albumin market are
    • Albumin Therapeutics, LLC
    • Albumedix A/S
    • CSL Behring LLC
    • Biotest AG
    • SeraCare Life Sciences (LGC)
    • HiMedia Laboratories Pvt. Ltd.
    • Grifols International, S.A.
    • Medxbio Pte Ltd.
    • InVitria
    • RayBiotech, Inc.
    • Takeda Pharmaceutical Company Limited (Shire)
    • Octapharma AG
    • Sigma-Aldrich Co. (Merck KGaA)

Albumin Market: Key Developments

  • Leading players in the global albumin market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to drive the global albumin market. A few expansion strategies adopted by players operating in the global albumin market are:
    • In November 2021, Grifols announced the release of its latest albumin portfolio innovation, ALBUTEIN FlexBag. It is a versatile container that allows for easy storage and greater convenience, as it does not require vented infusion sets or filters.
    • In July 2021, Grifols, a global leader in the production of plasma-derived medicines, partnered with the U.S. firm ImmunoTek Bio Centers LLC to build plasma centers
    • In April 2021, Albumedix announced the expansion of its research collaboration with Cobra Biologics, the gene therapy division of Charles River Laboratories International, Inc., and Cognate BioServices
    • In March 2021, Albumedix Ltd., a provider of advanced therapies and a world leader in recombinant human albumin (rHA), entered into a distribution agreement with FUJIFILM Wako Pure Chemical Corporation, an established and well-known reagent supplier
    • In July 2020, the European Medicines Agency (EMA), an agency of the European Union in charge of the evaluation and supervision of medicinal products, approved CSL Behring’s long-acting and novel Idelvion, a recombinant albumin fusion protein, in order to treat hemophilia B
    • In May 2020, Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies, introduced ALBUMINEX 5 percent (human albumin) solution and ALBUMINEX 25 percent for the treatment of hypovolemia, ascites, and hypoalbuminemia
  • The report on the global albumin market discusses individual strategies followed by company profiles of manufacturers of albumin devices. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global albumin market.

Albumin Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 4.6 Bn

Market Forecast Value in 2031

US$ 8.1 Bn

Growth Rate (CAGR)

6.1%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Human Serum Albumin
    • Recombinant Albumin
  • Application
    • Human Serum Albumin Applications
      • Drug Delivery
      • Drug Formulation
      • Medical Device Coating
      • Vaccines
      • Culture Medium & Stabilizer
      • In Vitro Fertilization
      • Diagnostics
    • Recombinant Albumin Applications
      • Drug Delivery
      • Drug Formulation
      • Medical Device Coating
      • Vaccines
      • Culture Medium & Stabilizer
      • In Vitro Fertilization
      • Diagnostics
  • End-user
    • Pharmaceutical & Biotechnology Companies
    • Research Institutes
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • U.K.
  • Germany
  • Italy
  • France
  • China
  • Spain
  • Japan
  • India
  • Australia & New Zealand
  • South Korea
  • Mexico
  • Brazil
  • South Africa
  • GCC Countries

Companies Profiled

  • Albumedix A/S (Novozyme A/S)
  • CSL Behring LLC
  • Biotest AG
  • Albumin Therapeutics, LLC
  • Grifols International, S.A.
  • HiMedia Laboratories Pvt. Ltd.
  • InVitria
  • Medxbio Pte Ltd.
  • Octapharma AG
  • RayBiotech, Inc.
  • SeraCare Life Sciences (LGC)
  • Sigma-Aldrich Co. (Merck KGaA)
  • Takeda Pharmaceutical Company Limited (Shire)
  • Other Prominent Players

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

Albumin market is expected to reach the value of US$ 8.1 Bn by the end of 2031

Albumin market is estimated to expand at a CAGR of 6.1% from 2021 to 2031

Albumin market is driven by increase in use of albumin to treat hypoalbuminemia in patients with chronic injuries

North America accounted for a major share of the global albumin market, owing to increase in demand for albumin in clinical research activities

Key players in the global albumin market include Biotest AG, CSL Behring LLC, HiMedia Laboratories Pvt. Ltd., Grifols International, S.A., Medxbio Pte Ltd.

Albumin Market – Scope of Report

TMR’s report on the global albumin market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global albumin market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global albumin market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global albumin market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global albumin market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global albumin market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global albumin market.

The report delves into the competitive landscape of the global albumin market. Key players operating in the global albumin market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global albumin market that have been profiled in this report.

Key Questions Answered in Global Albumin Market Report

  • What is the scope of growth of product companies in the global albumin market?
  • What will be the Y-o-Y growth of the global albumin market between 2017 and 2031?
  • What is the influence of changing trends in technologies on the global albumin market?
  • Will Asia Pacific be the most profitable market for albumin providers?
  • Which factors are anticipated to hamper the growth of the global albumin market during the forecast period?
  • Which are the leading companies in the global albumin market?

Research Methodology

TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global albumin market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global albumin market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the albumin market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the albumin market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global albumin market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global albumin market more reliably and accurately.

Albumin Market – Segmentation

Product Type
  • Human Serum Albumin
  • Recombinant Albumin
Application
  • Human Serum Albumin Applications
    • Drug Formulation
    • Drug Delivery
    • Vaccines
    • Medical Device Coating
    • Culture Medium & Stabilizer
    • Diagnostics
    • In Vitro Fertilization
  • Recombinant Albumin Applications
    • Drug Formulation
    • Drug Delivery
    • Vaccines
    • Medical Device Coating
    • Culture Medium & Stabilizer
    • Diagnostics
    • In Vitro Fertilization
End-user
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Albumin Market

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Albumin Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)

    5.2. Regulatory Scenario by Key Countries

    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Albumin Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Human Serum Albumin

        6.3.2. Recombinant Albumin

    6.4. Market Attractiveness Analysis, by Product

7. Global Albumin Market Analysis and Forecasts, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Human Serum Albumin Applications

            7.3.1.1. Drug Formulation

            7.3.1.2. Drug Delivery

            7.3.1.3. Vaccines

            7.3.1.4. Medical Device Coating

            7.3.1.5. Culture Media & Stabilizers

            7.3.1.6. Diagnostics

            7.3.1.7. In Vitro Fertilization

        7.3.2. Recombinant Albumin Applications

            7.3.2.1. Drug Formulation

            7.3.2.2. Drug Delivery

            7.3.2.3. Vaccines

            7.3.2.4. Medical Device Coating

            7.3.2.5. Culture Media & Stabilizers

            7.3.2.6. Diagnostics

            7.3.2.7. In Vitro Fertilization

8. Global Albumin Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Pharmaceutical & Biotechnology Companies

        8.3.2. Research Institutes

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Albumin Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Albumin Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Human Serum Albumin

        10.2.2. Recombinant Albumin

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Human Serum Albumin Applications

            10.3.1.1. Drug Formulation

            10.3.1.2. Drug Delivery

            10.3.1.3. Vaccines

            10.3.1.4. Medical Device Coating

            10.3.1.5. Culture Media & Stabilizers

            10.3.1.6. Diagnostics

            10.3.1.7. In Vitro Fertilization

        10.3.2. Recombinant Albumin Applications

            10.3.2.1. Drug Formulation

            10.3.2.2. Drug Delivery

            10.3.2.3. Vaccines

            10.3.2.4. Medical Device Coating

            10.3.2.5. Culture Media & Stabilizers

            10.3.2.6. Diagnostics

            10.3.2.7. In Vitro Fertilization

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Pharmaceutical & Biotechnology Companies

        10.4.2. Research Institutes

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Albumin Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Human Serum Albumin

        11.2.2. Recombinant Albumin

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Human Serum Albumin Applications

            11.3.1.1. Drug Formulation

            11.3.1.2. Drug Delivery

            11.3.1.3. Vaccines

            11.3.1.4. Medical Device Coating

            11.3.1.5. Culture Media & Stabilizers

            11.3.1.6. Diagnostics

            11.3.1.7. In Vitro Fertilization

        11.3.2. Recombinant Albumin Applications

            11.3.2.1. Drug Formulation

            11.3.2.2. Drug Delivery

            11.3.2.3. Vaccines

            11.3.2.4. Medical Device Coating

            11.3.2.5. Culture Media & Stabilizers

            11.3.2.6. Diagnostics

            11.3.2.7. In Vitro Fertilization

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Pharmaceutical & Biotechnology Companies

        11.4.2. Research Institutes

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By End-user

        11.6.3. By Country/Sub-region

12. Asia Pacific Albumin Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Human Serum Albumin

        12.2.2. Recombinant Albumin

    12.3. Market Value Forecast by Application, 2017–2031

        12.3.1. Human Serum Albumin Applications

            12.3.1.1. Drug Formulation

            12.3.1.2. Drug Delivery

            12.3.1.3. Vaccines

            12.3.1.4. Medical Device Coating

            12.3.1.5. Culture Media & Stabilizers

            12.3.1.6. Diagnostics

            12.3.1.7. In Vitro Fertilization

        12.3.2. Recombinant Albumin Applications

            12.3.2.1. Drug Formulation

            12.3.2.2. Drug Delivery

            12.3.2.3. Vaccines

            12.3.2.4. Medical Device Coating

            12.3.2.5. Culture Media & Stabilizers

            12.3.2.6. Diagnostics

            12.3.2.7. In Vitro Fertilization

    12.4. Market Value Forecast, by Product, 2017–2031

        12.4.1. Pharmaceutical & Biotechnology Companies

        12.4.2. Research Institutes

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. South Korea

        12.5.4. India

        12.5.5. Australia & New Zealand

        12.5.6. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Albumin Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Human Serum Albumin

        13.2.2. Recombinant Albumin

    13.3. Market Value Forecast by Application, 2017–2031

        13.3.1. Human Serum Albumin Applications

            13.3.1.1. Drug Formulation

            13.3.1.2. Drug Delivery

            13.3.1.3. Vaccines

            13.3.1.4. Medical Device Coating

            13.3.1.5. Culture Media & Stabilizers

            13.3.1.6. Diagnostics

            13.3.1.7. In Vitro Fertilization

        13.3.2. Recombinant Albumin Applications

            13.3.2.1. Drug Formulation

        13.3.3. Drug Delivery

            13.3.3.1. Vaccines

            13.3.3.2. Medical Device Coating

            13.3.3.3. Culture Media & Stabilizers

            13.3.3.4. Diagnostics

            13.3.3.5. In Vitro Fertilization

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Pharmaceutical & Biotechnology Companies

        13.4.2. Research Institutes

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Albumin Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2017–2031

        14.2.1. Human Serum Albumin

        14.2.2. Recombinant Albumin

    14.3. Market Value Forecast, by End-user, 2017–2031

        14.3.1. Pharmaceutical & Biotechnology Companies

        14.3.2. Research Institutes

        14.3.3. Others

    14.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.4.1. GCC Countries

        14.4.2. South Africa

        14.4.3. Rest of Middle East & Africa

    14.5. Market Attractiveness Analysis

        14.5.1. By Product

        14.5.2. By Application

        14.5.3. By End-user

        14.5.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2020

    15.3. Company Profiles

        15.3.1. Albumedix A/S

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Financial Analysis

            15.3.1.3. Growth Strategies

            15.3.1.4. SWOT Analysis

        15.3.2. Albumin Therapeutics, LLC

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Financial Analysis

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis

        15.3.3. Biotest AG

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Financial Analysis

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis

        15.3.4. CSL Behring LLC

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Financial Analysis

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5. Grifols International, S.A.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Financial Analysis

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis

        15.3.6. HiMedia Laboratories Pvt. Ltd.

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Financial Analysis

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis

        15.3.7. InVitria

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Financial Analysis

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis

        15.3.8. Medxbio Pte Ltd.

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Financial Analysis

            15.3.8.3. Growth Strategies

            15.3.8.4. SWOT Analysis

        15.3.9. Octapharma AG

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Financial Analysis

            15.3.9.3. Growth Strategies

            15.3.9.4. SWOT Analysis

        15.3.10. RayBiotech, Inc.

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Financial Analysis

            15.3.10.3. Growth Strategies

            15.3.10.4. SWOT Analysis

        15.3.11. Seracare Life Sciences (LGC)

            15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.11.2. Financial Analysis

            15.3.11.3. Growth Strategies

            15.3.11.4. SWOT Analysis

            15.3.11.5. SWOT Analysis

        15.3.12. Sigma-Aldrich Co. (Merck KGaA)

            15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.12.2. Financial Analysis

            15.3.12.3. Growth Strategies

            15.3.12.4. SWOT Analysis

        15.3.13. Takeda Pharmaceutical Company Limited (Shire)

            15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.13.2. Financial Analysis

            15.3.13.3. Growth Strategies

            15.3.13.4. SWOT Analysis

List of Tables

Table 01: Global Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 04: Global Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 05: Global Albumin Market Value (US$ Mn), Forecast, 2017–2031

Table 06: Global Albumin Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Albumin Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 09: North America Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 10: North America Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 11: North America Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 12: North America Albumin Market Value (US$ Mn), Forecast, by End-user, 2017–2031

Table 13: Europe Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Europe Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 15: Europe Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Europe Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 17: Europe Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 18: Europe Albumin Market Value (US$ Mn), Forecast, by End-user, 2017–2031

Table 19: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 20: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 21: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 22: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 23: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 24: Asia Pacific Albumin Market Value (US$ Mn), Forecast, 2017–2031

Table 25: Latin America Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 26: Latin America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Latin America Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 28: Latin America Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 29: Latin America Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 30: Latin America Albumin Market Value (US$ Mn), Forecast, 2017–2031

Table 31: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 32: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 33: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 34: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications,2017–2031

Table 35: Middle East & Africa Albumin Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017–2031

Table 36: Middle East & Africa Albumin Market Value (US$ Mn), Forecast, 2017–2031

List of Figures

Figure 01: Global Albumin market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Albumin market Value Share, by Product Type, 2020

Figure 03: Global Albumin market Value Share, by End-user, 2020

Figure 04: Global Albumin market Value Share, by Region, 2020

Figure 05: Global Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 06: Global Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 07: Global Albumin Market Revenue (US$ Mn), by Human Serum Albumin, 2017–2031

Figure 08: Global Albumin Market Revenue (US$ Mn), by Recombinant Albumin, 2017–2031

Figure 09: Global Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 10: Global Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 11: Global Albumin Market Revenue (US$ Mn), by Human Serum Albumin Applications, 2017–2031

Figure 12: Global Albumin Market Revenue (US$ Mn), by Recombinant Albumin Applications, 2017–2031

Figure 13: Global Albumin Market, by End-user, 2020 and 2031

Figure 14: Global Albumin Market, by End-user, 2021–2031

Figure 15: Global Albumin Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031

Figure 16: Global Albumin Market (US$ Mn), by Research Institutes, 2017–2031

Figure 17: Global Albumin Market (US$ Mn), by Others, 2017–2031

Figure 18: Global Albumin Market Value Share Analysis, by Region, 2020 and 2031

Figure 19: Global Albumin Market Attractiveness Analysis, by Region, 2021–2031

Figure 20: North America Albumin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 21: North America Albumin Market Value Share Analysis, by Country, 2020 and 2031

Figure 22: North America Albumin Market Attractiveness Analysis, by Country, 2021–2031 

Figure 23: North America Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 24: North America Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 25: North America Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 26: North America Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 27: North America Albumin Market, by End-user, 2020 and 2031

Figure 28: North America Albumin Market, by End-user, 2021–2031

Figure 29: Europe Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 30: Europe Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 31: Europe Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 32: Europe Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 33: Europe Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 34: Europe Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 35: Europe Albumin Market, by End-user, 2020 and 2031

Figure 36: Europe Albumin Market, by End-user, 2021–2031

Figure 37: Asia Pacific Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 38: Asia Pacific Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 39: Asia Pacific Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 40: Asia Pacific Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 41: Asia Pacific Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 42: Asia Pacific Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 43: Asia Pacific Albumin Market, by End-user, 2020 and 2031

Figure 44: Asia Pacific Albumin Market, by End-user, 2021–2031

Figure 45: Latin America Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 46: Latin America Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 47: Latin America Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 48: Latin America Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 49: Latin America Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 50: Latin America Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 51: Latin America Albumin Market, by End-user, 2020 and 2031

Figure 52: Latin America Albumin Market, by End-user, 2021–2031

Figure 53: Middle East & Africa Albumin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 54: Middle East & Africa Albumin Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031

Figure 55: Middle East & Africa Albumin Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 56: Middle East & Africa Albumin Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 57: Middle East & Africa Albumin Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 58: Middle East & Africa Albumin Market Value Share Analysis, by Application, 2020 and 2031

Figure 59: Middle East & Africa Albumin Market Attractiveness Analysis, by Application, 2021–2031

Figure 60: Middle East & Africa Albumin Market, by End-user, 2020 and 2031

Figure 61: Middle East & Africa Albumin Market, by End-user, 2021–2031

Figure 62: Global Albumin Market Share, by Company, 2021

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization